ARCHIVES

FDA to refer false statements by regulated companies to SEC.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Bush Vetoes HHS Budget Bill, House Votes To Sustain.

November 23, 2007

Arnold Brown Will Be Appointed NCI Director; Rauscher, Staff “Couldn’t Be More Pleased”

October 22, 1976

Protest Erupts Over Charge That NCAB Directives On CCOP Are Ignored; “Misunderstanding,” DeVita Says

June 25, 1982

Oxandrolone And Education Improves Weight Gain

February 28, 2003

In Brief: New Biomedical Research Panel To Organize Feb. 24-25, Discuss Mandate, Priorities

February 14, 1975

Emil Frei, Pioneer of Combination Chemotherapy, Dies at 89

May 10, 2013